Does Noom offer a referral program
Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
The LEADER trial for liraglutide and SUSTAIN-6 for semaglutide established cardiovascular benefit for that class
[PubMed ID: 27713388]
Had an opportunity to speak to Lilly's Winselow Tucker and Novo's Vikrant Shrotriya in two exclusive interviews as they detailed their strategies on pricing, market expansion, and how they plan to fend off a flood of cheaper generics to defend Mounjaro (tirzepatide) and Wegovy (semaglutide) in one of the worlds most price-sensitive markets
Adylxin FDA Safety Label Change Bydureon BCISE extended-release (exenatide synthetic) subcutaneous weekly injection FDA Approval Year: 2017 Bydureon Extended Release Safety Label Change Byetta (exenatide synthetic) subcutaneous twice-daily injection FDA Approval Year: 2005 Byetta FDA Safety Label Change Mounjaro (tirzepatide) subcutaneous weekly injection FDA Approval Year: 2022 The Gastrointestinal Adverse Reaction section added that a small number of patients have reported the experience of dysgeusia (altered sense of taste)